Determination of Color, Pigment, and Phenolic Stability of Non-Acylated Anthocyanins from Berberis boliviana L. in Yogurt Systems

As natural food products and colorants are on the verge of a new era, anthocyanins are of particular interest because of their known antioxidant power, beautiful color, and relative stability in high acid foods. This study focuses on the Peruvian berry Berberis boliviana, rich in phenolics and non-acylated anthocyanins (9 and 7% dry weight, respectively) Our objective was to determine color and pigment stability using different levels of Berberis boliviana whole fruit addition in comparison to purple carrot acylated anthocyanin extracts throughout various yogurt fat matrices. Yogurt samples with 0, 2, and 4% fat contents were colored using 10 and 20mg of Berberis boliviana anthocyanins. Yogurt samples were compared with FD&C Red 40, Betalaines, and Purple Carrot anthocyanin treatments, along with a negative control yogurt sample (no color added). All treatments were stored at 4ºC for 1, 7, 14, 30, 45, and 60 days. Yogurt color (CIELab, chroma, and hue angle) was measured with a Hunter ColorQuest. Anthocyanin and phenolic degradation kinetics was evaluated using the pH differential method and Folin Ciocalteau methods, respectively. Qualitative changes were monitored by HPLC coupled to a MS and PDA detectors. Initial color of the yogurt treatments containing Berberis boliviana anthocyanins showed very similar color characteristics (L=65, a*=12, b*=-6, chroma=14, and hue angle=335º) to commercial blueberry yogurt (L=65, a*=10, b*=-3.5, chroma=10.5, and hue angle=341º) colored with FD&C Red 40 and Blue 1. Color and pigment stability was achieved in both acylated and non-acylated anthocyanins throughout the study and was related to the fat content of the matrix. The added stability of acylated pigments did not result in a marked difference throughout the shelf life of the yogurt (typically 30 days). Addition of Berberis boliviana whole fruit to yogurt resulted on an attractive and marketable added value product with acceptable stability for commercial applications.The IFT FoundationThe Tinker Field Research Grant Foundatio

Dietary Bioactives and Bone Health

There is general agreement within the fields of food, nutrition, and medical sciences that an individual’s diet and lifestyle can substantially predispose one to, or protect against osteoporosis, low bone mass, and numerous other age-related bone diseases. Dietary bioactives, found diversity in a variety of foods from fruits to vegetables, herbs and spices, essential oils and beverages, have the potential to influence bone health. The NIH Office of Dietary Supplements has defined dietary bioactives as “compounds that are constituents in foods and dietary supplements, other than those needed to meet basic human nutritional needs, which are responsible for changes in health status.” These compounds are generally thought to be safe in food at normal consumption levels (e.g., polyphenols in plant foods). Dietary bioactives are currently being assessed for their properties beyond antioxidant capacity, including anti-inflammatory actions. Some compounds or classes of compounds have been reported to enhance bone formation and inhibit bone resorption through their actions on cell signaling pathways that influence osteoblast and osteoclast differentiation. Emerging scientific evidence is available, including observational studies and small clinical interventions that suggest consumption of certain dietary bioactives may have beneficial effects on bone health. Animal models have the unique advantage of feeding controlled diets for extended periods of time to assess long-term changes in bone. While bone mineral density (BMD) is the gold standard for assessing fracture risk, other factors such as bone structure, including trabecular thickness and separation, influence bone strength. Bone turnover rate is also predictive of fracture. Future research is needed to determine the types and quantities of dietary bioactives that are most effective and at what dose, as well as the mechanisms involved in modulating cellular events, in order to set precedence for larger clinical trials

Health-Promoting Components of Fruits and Vegetables in Human Health

Diet and lifestyle choices can substantially predispose an individual to, or protect against, many age- and obesity-related chronic diseases. According to the NIH Office of Dietary Supplements, dietary bioactives arecompounds in foodsnot needed for basic human nutrition but responsible for changes in health status.1 These compounds are safe at normal food consumption levels (e.g., anthocyanins in berries) and their biological activities may come from a single compound (e.g., lutein in spinach) or a class of compounds (e.g., avenanthramides in oats) even if the exact identity and composition are unknown. Bioactive compounds of plants; can vary significantly in their ratios and relative concentrations depending onfactors such as cultivation, soil, altitude, and weather conditions. Substantial scientific evidence is available for some health promoting phytochemicals, such as dose-response relations, for performance and/or reduction in the risk of chronic disease. However, several limitations relating to absorption, distribution, metabolism and excretion of many dietary bioactives still exist and must be better understood This Special Issue compiles recent discoveries that advance our understanding of how dietary bioactive, particularly from fruits and vegetables, influence long-term health maintenance and disease prevention

Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner

Oats contain unique bioactive compounds known as avenanthramides (AVAs) with antioxidant properties. AVAs might enhance the endogenous antioxidant cellular response by activation of the transcription factor Nrf2. Accumulation of reactive oxygen species plays a critical role in many chronic and degenerative diseases, including osteoporosis. In this disease, there is an imbalance between bone formation by osteoblasts and bone resorption by osteoclasts, which is accompanied by increased osteoblast/osteocyte apoptosis and decreased osteoclast apoptosis. We investigated the ability of the synthethic AVAs 2c, 2f and 2p, to 1-regulate gene expression in bone cells, 2-affect the viability of osteoblasts, osteocytes and osteoclasts, and the generation of osteoclasts from their precursors, and 3-examine the potential involvement of the transcription factor Nrf2 in these actions. All doses of AVA 2c and 1 and 5 µM dose of 2p up-regulated collagen 1A expression. Lower doses of AVAs up-regulated OPG (osteoprotegerin) in OB-6 osteoblastic cells, whereas 100 μM dose of 2f and all concentrations of 2c down-regulated RANKL gene expression in MLO-Y4 osteocytic cells. AVAs did not affect apoptosis of OB-6 osteoblastic cells or MLO-Y4 osteocytic cells; however, they prevented apoptosis induced by the DNA topoisomerase inhibitor etoposide, the glucocorticoid dexamethasone, and hydrogen peroxide. AVAs prevented apoptosis of both wild type (WT) and Nrf2 Knockout (KO) osteoblasts, demonstrating that AVAs-induced survival does not require Nrf2 expression. Further, KO osteoclast precursors produced more mature osteoclasts than WT; and KO cultures exhibited less apoptotic osteoclasts than WT cultures. Although AVAs did not affect WT osteoclasts, AVA 2p reversed the low apoptosis of KO osteoclasts. These in vitro results demonstrate that AVAs regulate, in part, the function of osteoblasts and osteocytes and prevent osteoblast/osteocyte apoptosis and increase osteoclast apoptosis; further, these regulatory actions are independent of Nrf2

Perforated Small Intestine: A Case of a Delayed Presentation of an Intra-Abdominal Injury in a Pediatric Patient With a Seatbelt Sign

With the use of seatbelts comes a unique injury profile that has been called "the seatbelt syndrome." The classically described "seatbelt sign" has become a pattern of injury, describing potential underlying damage. As a clinician, clues to the underlying damage follow a thorough physical examination including the removal of all clothing to locate abrasions and bruises to the skin that potentially follow a seatbelt pattern. Delayed presentation of an intra-abdominal injury in the setting of a seatbelt sign has been well documented; however, the question is how long to observe these patients. We present the case of a 17-year-old woman involved in a motor vehicle collision who presented to the emergency department (ED) hemodynamically stable with a lower abdominal wall seatbelt sign. Her initial imaging revealed only an abdominal wall contusion. She was admitted for observation. Approximately 12 h later she started developing abdominal pain, and by 14 h abdominal distention, with repeat imaging showing free fluid and free air. She was taken to the operating room for an exploratory laparotomy and was ultimately discharged back home on day 7

Strong electron-phonon coupling in delta-phase stabilized Pu

Heat capacity measurements of the delta-phase stabilized alloy Pu-Al suggest that strong electron-phonon coupling is required to explain the moderate renormalization of the electronic density of states near the Fermi energy. We calculate the heat capacity contributions from the lattice and electronic degrees of freedom as well as from the electron-lattice coupling term and find good overall agreement between experiment and theory assuming a dimensionless electron-phonon coupling parameter of order unity, lambda ~ 0.8. This large electron-phonon coupling parameter is comparable to reported values in other superconducting metals with face-centered cubic crystal structure, for example, Pd (lambda ~ 0.7) and Pb (lambda ~ 1.5). Further, our analysis shows evidence of a sizable residual low-temperature entropy contribution, S_{res} ~ 0.4 k_B (per atom). We can fit the residual specific heat to a two-level system. Therefore, we speculate that the observed residual entropy originates from crystal-electric field effects of the Pu atoms or from self-irradiation induced defects frozen in at low temperatures.Comment: 9 pages, 11 figures, to appear in Phys. Rev.

A tubo-ovarian abscess mimicking an appendiceal abscess: a rare presentation of Streptococcus agalactiae.

A tubo-ovarian abscess (TOA) is a relatively rare medical complication that results from an untreated/unrecognized ascending pelvic infection of the female genital tract. In a right-sided TOA, this clinical entity may mimic appendicitis on computed tomography (CT). In addition, both disease processes can present with pelvic pain, leukocytosis and fever. We present the case of a 47-year-old female with mid right-sided abdominal pain that was diagnosed on CT scan with an appendiceal abscess. She underwent CT-guided percutaneous drainage with interventional radiology. On Day 8, a CT limited study involving a contrast injection was performed to evaluate for abscess resolution. The contrast within the drain filled the fallopian tube, endometrial cavity and contralateral fallopian tube. These findings demonstrated that the initial diagnosis actually represented a TOA. To the authors\u27 knowledge, this is the only reported case involving a TOA secondary to Streptococcus agalactiae (GBS) mimicking an appendicitis with abscess formation

Pilot Visual Detection of Small Unmanned Aircraft on Final Approach during Nighttime Conditions

In December 2020, the Federal Aviation Administration (FAA) announced the release of a new final rule, permitting operators of small unmanned aircraft systems (sUAS) to perform routine night operations. Public comments to the Notice of Proposed Rulemaking indicated potential safety concerns regarding a pilot’s ability to spot a low-altitude sUAS during nighttime conditions. Leveraging data from the FAA’s UAS Sighting Report Database, the research team evaluated the significance of aircraft encounters with UAS at night. Researchers conducted an inflight experiment in which 10 pilots performed an instrument approach to airport during nighttime conditions in which a multi-rotor sUAS presented a potential collision hazard. The sUAS was equipped with lighting visible for 3 miles with a sufficient flash rate to avoid a collision, as specified by the new regulation. Participants performed five approaches, with the sUAS flying different scripted encounter profiles. Participants were asked to indicate when they visually spotted the sUAS, with sighting data recorded via an onboard observer. Geolocation information from both the aircraft and sUAS were compared at the time of each reported sighting to assess visibility distance and orientation. The sUAS was successfully spotted during 30 percent (n = 12) of the testing passes. Hovering sUAS were spotted at the same rate as moving sUAS, however, sUAS in motion were spotted at a much greater range. Researchers noted disproportionately higher spotting rates occurred when the sUAS was oriented on the starboard side of the aircraft vs. the port side. It is believed that airport lighting systems may have obscured or otherwise camouflaged portside sUAS encounters. When asked to estimate distance to an encountered sUAS, most participants underestimated, perceiving the sUAS to be much closer than reality. Additionally, the researchers assessed the potential for the participants to initiate evasive maneuvers, based on the distance and closure rate of the aircraft and sUAS at the time of sighting. Based on the FAA’s Aircraft Identification and Reaction Time Chart, collision avoidance would only have been successful during 15 percent of encounters (n = 6). The research team recommends Remote Pilots employ vigilant traffic awareness during nighttime operations, and leverage use of ADS-B (In) technology and monitor Common Traffic Advisory Frequencies to maintain situational awareness—particularly when operating in proximity to airports